A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: procedure (650), etiquette (1), practice (609)

Atezolizumab

Description
Chemotherapy Protocol GENITOURINARY CANCER Atezolizumab Regimen • Bladder – Atezolizumab Indication • The treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab.pdf

Cabozantinib

Description
Chemotherapy Protocol RENAL CELL CANCER Regimen CABOZANTINIB • Renal Cell – Cabozantinib (60mg-tablets) Indication • Cabozantinib s indicated for the treatment of advanced
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Cabozantinib.pdf

Axitinib v1.2

Description
Chemotherapy Protocol RENAL CELL AXITINIB This regimen may require funding Regimen Renal Cell - Axitinib Indication Second line treatment of advanced or
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Axitinib-v1.2.pdf

Gemcitabine-Vinorelbine Ver1.1

Description
Chemotherapy Protocol LYMPHOMA GEMCITABINE-VINORELBINE Regimen Lymphoma – Gemcitabine-Vinorelbine Indication Relapsed or refractory Non-Hodgkin’s Lymphoma Relapsed or refractory Hodgkin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Gemcitabine-Vinorelbine-Ver1.1.pdf

GDP-Cisplatin-Dexamethasone-Gemcitabine

Description
Chemotherapy Protocol LYMPHOMA CISPLATIN-DEXAMETHASONE-GEMCITABINE (GDP) Regimen • Lymphoma – GDP-Cisplatin-Dexamethasone-Gemcitabine Indication • Hodgkin’s Lymphoma Toxicity Drug Cisplatin Dexamethasone
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/GDP-Cisplatin-Dexamethasone-Gemcitabine.pdf

FC IV (3 day)-Cyclophosphamide-Fludarabine IV (3 day) Ver 1.1

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE–FLUDARABINE INTRAVENOUS (FC IV 3 day) Regimen Lymphoma – FC IV (3 day)- Cyclophosphamide-Fludarabine IV (3 day
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/FC-IV-3-day-Cyclophosphamide-Fludarabine-IV-3-day-Ver-1.1.pdf

CHOP(21)-Cyclophosphamide-Doxorubicin-Prednisolone-Vincristine (21) Ver 1.2

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-PREDNISOLONE-VINCRISTINE (21) (CHOP 21) Regimen Lymphoma – CHOP(21)-Cyclophosphamide-Doxorubicin-Prednisolone-Vincristine (21) Indication Non
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/CHOP21-Cyclophosphamide-Doxorubicin-Prednisolone-Vincristine-21-Ver-1.2.pdf

ChlVPP-Chlorambucil-Prednisolone-Procarbazine-Vinblastine Ver 1.1

Description
Chemotherapy Protocol LYMPHOMA CHLORAMBUCIL-PREDNISOLONE-PROCARBAZINE-VINBLASTINE (ChlVPP) Regimen Lymphoma – ChlVPP-Chlorambucil-Prednisolone-Procarbazine-Vinblastine Indication Hodgkin’s Lymphoma Toxicity Drug
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/ChlVPP-Chlorambucil-Prednisolone-Procarbazine-Vinblastine-Ver-1.1.pdf

CEOP-Cyclophosphamide-Etoposide-Prednisolone-Vincristine Ver 1.2

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-ETOPOSIDE-PREDNISOLONE-VINCRISTINE Regimen (CEOP) Lymphoma – CEOP-Cyclophosphamide-Etoposide-Prednisolone-Vincristine Indication Non-Hodgkin’s Lymphoma where
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/CEOP-Cyclophosphamide-Etoposide-Prednisolone-Vincristine-Ver-1.2.pdf

InP DoxorubicinIfosfamideVer1

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-IFOSFAMIDE In-Patient Regimen Regimen Sarcoma – InP-Doxorubicin - Ifosfamide Indication Soft tissue sarcoma WHO performance status 0
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPDoxorubicinIfosfamideVer1.pdf
481 to 490 of 698
Previous … 47 48 49 50 51 … Next